October 2018

On Monday, October 15, 2018, member companies of the Pharmaceutical Research and Manufacturers of America (PhRMA) announced a…

On September 21, 2018, the Centers for Disease Control (CDC) issued a publication, “Implementing the CDC Guidelines for…

Earlier this year in the state of New Jersey, a state senator introduced Senate Bill 977, “Prohibits excessive charges for drugs…

On October 11, 2018, New York Attorney General Barbara D. Underwood announced a settlement with Pfizer, Inc. for deceptive…

On Wednesday, October 17th at 9:00am ET, the Academy for Continued Healthcare Learning (ACHL) will present CME and MACRA: The…

On Tuesday, September 18, 2018, California’s insurance commissioner filed a complaint against AbbVie, Inc., alleging a kickback…

Government oversight is coming to the Open Payments program. Recently, the Centers for Medicare and Medicaid Services (CMS)…

Mintz Levin recently reviewed unsealed healthcare-related qui tam cases in early 2018, identifying a total of forty-six cases…

Arena Pharmaceuticals has been focused recently on researching and developing a non-opiate for the treatment of gastrointestinal…

We previously wrote about the California legislation that established a statewide take-back system for sharps and medications. On…